Table 1:

Survey of Antibiotic Loaded Bone Cement Uses by Surgeons in the 2019 ALBC-RW

Question 1	Do you use ALBC in total joint arthroplasty/PJI in your practice? Response: Yes = 100%
Question 1a	If yes, in which indication? Response: 38% of the surgeons use it for all cemented primary arthroplasties, and 67% in primary arthroplasties with patients at risk for infection (diabetes, rheumatoid arthritis, obesity etc.). All surgeons use it for revision arthroplasty cases, particularly in periprosthetic joint infections.
Question 2	What is the best anecdotal evidence you have that ALBC in total joint arthroplasty/PJI is efficacious in your patients? Response: “none” (27%), “low reinfection rates in my own case series” (27%), “good registry data confirming the benefit of ALBC in primary arthroplasty” (7%), “conflicting data from registries” (7%), “the Canadian register did not show any difference in PJI rates”, “I do not feel that ALBC is harmful and thus I use it on a theoretical advantage” (7%), other responses (28%).
Question 3	Do you think that more prospective randomized controlled trials (RCTs) data are required for ALBC for 2-stage revision surgery with ALBC? Response: Yes = 47%; No = 29%; Undecided = 24%
Question 4	Do you think that more prospective randomized controlled trials (RCTs) data are required for primary arthroplasty with ALBC? Response: Yes = 47%; No = 29%; Undecided = 24%